Genetic diversity of Plasmodium falciparum field isolates from south western Nigeria.

BACKGROUND Plasmodium falciparum the main causative agent of malaria is an important public health vector. With the use of PCR, its genetic diversity has been extensively studied with dearth information from Nigeria. METHODS In this study, 100 P. falciparum strains merozoite surface protein 1(msp-1), merozoite surface protein 2 (msp-2) and Glutamate rich protein (Glurp) from Ogun State General Hospitals were characterized. The genetic diversity of P. falciparum isolates was analyzed by restriction fragment length polymorphism following gel electrophoresis of DNA products from nested polymerase chain reactions (PCR) of their respective allelic families KI, MAD 20, RO33 (MSP-1);FC27, 3D7 (MSP-2) and Glutamate rich protein respectively. RESULTS Majority of the patients showed monoclonal infections while multiplicity of the infection for msp-1 and msp-2 were 1.1 and 1.2 respectively. The estimated number of genotypes was 8 msp-1 (4 KI; 3 MAD; 1 RO33) and 6 msp-2 (3 FC27; 3 3D7). 80% of the isolates coded for Glurp with allelic size ranged between 700 and 900 bp. CONCLUSION The allelic distributions however were similar to those previously reported in other endemic malaria countries. Future studies will be designed to include other malaria endemic regions of Nigeria such as the oil exploration regions.

[1]  S. Fatumo,et al.  In-silico studies of multi drug resistance (MDR) genetic markers of Plasmodium species , 2010 .

[2]  Sándor Bereczky,et al.  Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2 , 2010, Malaria Journal.

[3]  S. Fatumo,et al.  In-Silico detection of chokepoints enzymes in four plasmodium species , 2009 .

[4]  G. Kiwanuka,et al.  Genetic diversity in Plasmodium falciparum merozoite surface protein 1 and 2 coding genes and its implications in malaria epidemiology: a review of published studies from 1997-2007. , 2009, Journal of vector borne diseases.

[5]  H. Ginsburg,et al.  Ethnopharmacology and malaria: new hypothetical leads or old efficient antimalarials? , 2008, International journal for parasitology.

[6]  R. Tahar,et al.  Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children. , 2007, Acta tropica.

[7]  O. Branch,et al.  Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: additional complexity and selection and convergence in fragment size polymorphism. , 2006, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[8]  Monica Cheesbrough,et al.  District Laboratory Practice in Tropical Countries, Part 2 , 2005 .

[9]  Andrew J Tatem,et al.  The global distribution and population at risk of malaria: past, present, and future. , 2004, The Lancet. Infectious diseases.

[10]  A. Cowman,et al.  Allelic polymorphisms in apical membrane antigen‐1 are responsible for evasion of antibody‐mediated inhibition in Plasmodium falciparum , 2004, Molecular microbiology.

[11]  A. Escalante,et al.  Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of the Plasmodium falciparum merozoite surface antigen-2 gene in isolates from symptomatic patients. , 2004, The American journal of tropical medicine and hygiene.

[12]  L. Gerena,et al.  Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. , 2004, The American journal of tropical medicine and hygiene.

[13]  L. Gerena,et al.  Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria , 2003, Annals of tropical medicine and parasitology.

[14]  P. Ringwald,et al.  Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. , 2000, The American journal of tropical medicine and hygiene.

[15]  R. Anders,et al.  The Malaria Antigens , 1999 .

[16]  M. Wahlgren,et al.  Malaria: molecular and clinical aspects , 1999 .

[17]  W. Jarra,et al.  Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  I. Felger,et al.  Genotypes of merozoite surface protein 2 of Plasmodium falciparum in Tanzania. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  R. Coppel,et al.  Temporal Variation of the Merozoite Surface Protein-2 Gene of Plasmodium falciparum , 1998, Infection and Immunity.

[20]  K. Kain,et al.  Distinguishing Plasmodium falciparum treatment failures from reinfections by restrictions fragment length polymorphism and polymerase chain reaction genotyping. , 1997, The American journal of tropical medicine and hygiene.

[21]  J. Lines,et al.  Population structure of Plasmodium falciparum in villages with different malaria endemicity in east Africa. , 1997, The American journal of tropical medicine and hygiene.

[22]  B. Fenton,et al.  Polymorphism of a 35-48 kDa Plasmodium falciparum merozoite surface antigen. , 1989, Molecular and biochemical parasitology.

[23]  R. Coppel,et al.  Identification of two integral membrane proteins of Plasmodium falciparum. , 1988, Proceedings of the National Academy of Sciences of the United States of America.